OHSU Knight Cancer Institute

OHSU Knight Cancer Institute A leader in cancer research, the OHSU Knight Cancer Institute provides individually tailored, compassionate care, from diagnosis through survivorship.
(585)

Congratulations to Dr. Melissa Wong on receiving the Rood Family Endowed Professorship in Cancer Research.Dr. Wong's res...
01/27/2026

Congratulations to Dr. Melissa Wong on receiving the Rood Family Endowed Professorship in Cancer Research.

Dr. Wong's research focuses on stem cell regulation in intestinal development, tissue regeneration and disease.

Learn more: https://bit.ly/4k04N2f

01/23/2026
“The second I talked to Dr. Sood, it was just calm. I had someone with answers. I have this rare appendix cancer — how l...
01/23/2026

“The second I talked to Dr. Sood, it was just calm. I had someone with answers. I have this rare appendix cancer — how lucky am I that there’s this specialist 15 minutes from my house?”

- Matthew Ross, who created a documentary to chronicle his cancer journey, which included a specialized procedure to treat his appendix cancer, which had spread aggressively into other parts of his abdomen:

A week after being diagnosed with appendix cancer, filmmaker Matthew Ross began filming. His ensuing film documents how OHSU saved his life.

"Exercise helps you tolerate cancer treatment better. If you experience less side effects, you are more likely to comple...
01/22/2026

"Exercise helps you tolerate cancer treatment better. If you experience less side effects, you are more likely to complete treatment, which leads to better outcomes."

- Dr. Kerri Winters-Stone on whether exercise is "a new breast cancer drug" (via WebMD):

Learn how exercise may help lower the chances of your breast cancer returning.

01/16/2026

Meet OHSU’s Dr. Ronald Ng

“When I meet with someone for the first time, we talk about their cancer, their disease, but we also talk about them, and what may be important to them.

It's important because what's important to everyone is different. The most gratifying part of my job is knowing that I was able to help someone and make a difference, no matter how small it may be.” - Dr. Ronald Ng

Get to know Dr. Ng, a medical oncologist who treats patients with prostate cancer, bladder cancer, kidney cancer, and other cancers of the genitourinary system:

01/13/2026
During a segment on College GameDay before the Orange Bowl, both Coach Dan Lanning and Pat McAfee Show generously donate...
01/09/2026

During a segment on College GameDay before the Orange Bowl, both Coach Dan Lanning and Pat McAfee Show generously donated $100K each to the OHSU Knight Cancer Institute!

Appreciate you, Coach and Pat! Best of luck tonight in the Peach Bowl 🦆

Dan Lanning missed Pat McAfee's GameDay challenge but still committed $100K of his own money. Here's what happened.

“The Community Partnership Program has helped us to make this program possible.Last year we helped more than 300 cancer ...
01/06/2026

“The Community Partnership Program has helped us to make this program possible.

Last year we helped more than 300 cancer patients and caregivers through our cancer support program, and we look forward to helping even more.”

- Erik Szeto, founder of the Asian Health and Service Center:

The Community Partnership Program invests in programs across Oregon designed by local communities, for local communities.

OHSU researchers analyzed more than 300 acute myeloid leukemia, or AML, patient samples and found that pairing venetocla...
12/31/2025

OHSU researchers analyzed more than 300 acute myeloid leukemia, or AML, patient samples and found that pairing venetoclax, a standard AML drug, with palbociclib, a cell-cycle inhibitor currently approved for breast cancer, produced significantly stronger and more durable anti-leukemia activity than venetoclax alone.

More than 20,000 Americans are diagnosed with AML each year, making it one of the most common types of leukemia — and one of the most aggressive. https://bit.ly/4sprXTt

Scientists identified a new drug combination that could overcome treatment resistance in acute myeloid leukemia.

"Having a blood test that detects a signal for a cancer in somebody with no symptoms and then seeing it confirmed on ima...
12/30/2025

"Having a blood test that detects a signal for a cancer in somebody with no symptoms and then seeing it confirmed on imaging? It’s a game-changer. It’s completely revolutionary." - Nima Nabavizadeh, MD, Chief medical officer for the OHSU Knight Cancer Institute's Cancer Early Detection Advanced Research Center, or CEDAR.

Dr. Nabavizadeh is the principal investigator for the PATHFINDER 2 study, the largest interventional multi-cancer early detection, or MCED, trial in North America examining the safety and efficacy of Grail’s Galleri MCED blood test to screen for cancers.

OHSU radiation oncologist presents promising study findings, launches a third, Medicare-backed study.

This season of giving, help us at OHSU do what we do best — provide exceptional health care for those in need in our com...
12/23/2025

This season of giving, help us at OHSU do what we do best — provide exceptional health care for those in need in our community — by making a gift today.

Your generosity will make the new year bright and ignite hope for OHSU and Doernbecher Children’s Hospital patients, health care professionals, scientists, students, and communities: https://bit.ly/4pU5qMO

Address

3181 SW Sam Jackson Park Road
Portland, OR
97239

Alerts

Be the first to know and let us send you an email when OHSU Knight Cancer Institute posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to OHSU Knight Cancer Institute:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category